{
  "id": 2916491,
  "title": "Powerful Growth, Multiple Endorsements Bode Well for Oracle Stock",
  "url": "https://urgent.news/2026/08/22/powerful-growth-multiple-endorsements-bode-well-for-oracle-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T18:30:02.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/powerful-growth-multiple-endorsements-bode-183002613.html"
  },
  "original_language": "en",
  "account": "Oracle (ORCL) stock appears to be an attractive investment opportunity, given its robust growth, low valuation, and strong endorsements from several prominent investors and research firms. The company benefited significantly from the ongoing AI revolution, which led to a 21% increase in revenue and a 24% jump in earnings per share (excluding certain items) in its fiscal fourth quarter that ended in May. Its cloud revenue, driven by AI, grew by 47% year-over-year to $9.9 billion, while its remaining performance obligations (RPO) surged 363% year-over-year to $638 billion, with most of the increase coming from AI contracts.\n\nRenowned investor Paul Tudor Jones recently acquired a significant position in ORCL stock, following his successful prediction of the 1987 stock market crash. His hedge fund, Tudor Investment Corp., was dubbed the pioneer of the modern hedge fund industry and has a net worth estimated at over $8 billion. Mizuho reiterated an \"Outperform\" rating and a $320 price target on Oracle in June, citing the company's strong earnings and conservative fiscal 2027 growth guidance of 34% without currency fluctuations. Guggenheim also reiterated its \"Buy\" rating and $400 price target after meeting with Oracle's CFO, who assured the executive that the AI infrastructure buildout does not pose any risk to the firm.\n\nResearch firm Zacks believes that the demand for Oracle's offerings is growing faster than the company can provide, implying that Oracle's profit margins will likely continue to climb. Despite the stock's low forward price-earnings ratio of 22.6x, Oracle's impressive growth and strong endorsements suggest that it could be a valuable addition to both value and growth investors' portfolios.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}